This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Marsh & McLennan Companies' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Marsh & McLennan Companies (MMC)

Q1 2012 Earnings Call

May 01, 2012 8:30 am ET

Executives

Brian Duperreault - Chief Executive Officer, President, Director, Member of Finance Committee and Member of Executive Committee

Daniel S. Glaser - Chief Operating Officer and Group President

J. Michael Bischoff - Chief Financial Officer

John P. Drzik - Chief Executive Officer of Oliver Wyman Group and President of Oliver Wyman Group

Julio A. Portalatin - Chief Executive Officer of Mercer and President of Mercer

Analysts

Keith F. Walsh - Citigroup Inc, Research Division

Larry Greenberg - Langen McAlenney

Brian Meredith - UBS Investment Bank, Research Division

Yaron Kinar - Deutsche Bank AG, Research Division

Jay Gelb - Barclays Capital, Research Division

Dan Farrell - Sterne Agee & Leach Inc., Research Division

Jay A. Cohen - BofA Merrill Lynch, Research Division

Raymond Iardella - Macquarie Research

Meyer Shields - Stifel, Nicolaus & Co., Inc., Research Division

Michael Zaremski - Crédit Suisse AG, Research Division

Michael Nannizzi - Goldman Sachs Group Inc., Research Division

Adam Klauber - William Blair & Company L.L.C., Research Division

Presentation

Operator

Welcome to Marsh & McLennan Companies Conference Call. Today's call is being recorded. First quarter 2012 financial results and supplemental information were issued earlier this morning. They are available on Marsh & McLennan Companies' website at www.mmc.com.

Before we begin, I would like remind you that remarks made today may include statements relating to future events or results, which are forward-looking statements, as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to inherent risks and uncertainties. In particular, references during this conference call to anticipated or expected results of operations for 2012 or subsequent periods are forward-looking statements and Marsh & McLennan Companies' actual results may be affected by a variety of factors.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs